What is the success rate of in vitro fertilization in the United States? Complete analysis of authoritative data

What is the success rate of in vitro fertilization in the United States? "- This is a question asked by almost all families preparing to go to the United States for assisted reproduction during their first consultation. The answer may seem like a percentage, but it affects all subsequent decisions: is it worth crossing the ocean? How many cycle budgets should be prepared? Which hospital should I choose? In fact, the "ART Success Rates Report" jointly released annually by the Centers for Disease Control and Prevention (CDC) and the National Surveillance System for Assisted Reproductive Technology (NASS) is regarded as the most authoritative and complete public database by peers worldwide. This article takes the latest complete annual report released in December 2022 (including the 2020 launch cycle) as the core, combined with the proceedings of the American Society for Reproductive Medicine (ASRM) 2023 conference and the peer review of the journal Fertility and Sterility, to dissect the calculation logic behind the "success rate", hospital differences, age thresholds, laboratory variables, and common misconceptions in cross-border medical treatment. It helps readers understand the official table within 10 minutes and establish their own "expected value model".

1、 How does CDC define 'success rate' - four common indicators

Open the CDC official website, and each hospital page will display four data items simultaneously: 1 Live Birth per Egg Retrieval; 2. Live Birth per Embryo Transfer rate per transplantation cycle; 3. Live Birth per Initiated Cycle; 4. Singleton Term Live Birth Rate. Their denominators are different, and the results can differ by nearly twice. For example, in a well-known center in 2020, the live birth rate of autologous test tubes under 35 years old was 63.4% per egg retrieval cycle, while the live birth rate per initiation cycle was only 55.1%. The difference comes from the cancellation of cycles (low ovarian response, premature ovulation, sudden endometrial abnormalities, etc.). Therefore, if you only receive a promotional flyer with a "success rate of 70%", ask the corresponding denominator first, otherwise it is easy to develop an overly optimistic attitude of "holding a baby for the first time".

2、 US Average: 2020 Fresh Cycle Statistics

In 2020, a total of 194358 cycles were initiated in the United States, including 132988 for fresh egg retrieval and 61370 for thawing transplantation. The overall data was affected by COVID-19, with a brief shutdown in March and April, but the completion rate for the whole year still reached 92%. The CDC divides age into five categories:<35, 35-37, 38-40, 41-42, and>42, with each category further distinguishing between autologous/allogeneic eggs and fresh/thawed eggs. The most relevant "autologous egg+fresh+singleton" curve for middle and high-income cross-border patients is as follows:

Interpretation: 1 The live birth rate decreases in a stepwise manner with age, with 38 years old being a clear watershed; 2. Under the age of 35, nearly half of women still need two egg retrieval attempts to hold their babies; 3. The rate of single full-term pregnancy is about 10 percentage points lower than the total live birth rate, which means that multiple pregnancies account for about 10%; 4. The average number of embryos transferred should be controlled between 1.2-1.8, reflecting the strict limitations of the ASRM guidelines in reducing the risk of multiple pregnancies in the United States.

3、 Thawing cycle: catching up with freshness

After the popularization of vitrification freezing technology, the survival rate of thawed embryos is ≥ 95%, and the endometrial preparation plan is more flexible. The thawing cycle accounted for 47.8% of the total number of transplants in 2020, and its live birth rate per transplant was better than that of fresh cycles in different age groups, with an average increase of 6-8 percentage points. There are two reasons: 1 After chromosome screening (PGT-A), only diploid embryos are implanted; 2. The synchronization between endometrial and embryonic development is better. For cross-border patients, if genetic testing is required or they need to wait for uterine surgery recovery, the "egg retrieval complete freezing subsequent thawing" plan has become mainstream.

4、 Laboratory technical dimensions: blastocyst culture PGT-A、Time-lapse

The CDC table does not directly disclose the "blastocyst rate", but ASRM will disclose in 2023 that the average blastocyst formation rate in the United States was 52.6% in 2020, with top centers reaching up to 70%. Embryo transfer increases the live birth rate of the<35 year old group to over 65%. The prevalence rate of PGT-A in women over 35 years old is 42%, and its detection rate of diploid embryos decreases with age: about 60% at 35 years old, 40% at 40 years old, and only 28% at 42 years old. Although Time lapse incubators have not been proven to independently increase live birth rates, they can reduce the number of embryo retrieval observations and improve laboratory efficiency. When choosing a hospital, you can check the "Laboratory Technology" section on the SART (Society for Reproductive Medicine) official website to confirm if the above configuration is available.

5、 Real hospital ranking list: 2020 CDC data (autologous eggs+fresh+<35 years old)

The following ranking is based on the live birth rate per egg retrieval cycle and only includes hospitals with an annual cycle of ≥ 100 and complete reports publicly available to the CDC to avoid "small sample outliers".

Note: The live birth rate does not necessarily mean success once, nor does it represent individual probability; The larger the number of cycles, the higher the statistical reliability. If the hospital does not appear on the CDC list or the number of cycles is less than 20, careful verification should be carried out.

6、 Five individual factors beyond age that affect success rate

1. Ovarian reserve: When AMH<1.0 ng/mL, even at the age of<35, the live birth rate per egg retrieval cycle will decrease to around 30%. 2. Uterine structure: Submucosal fibroids ≥ 4 cm, uterine septum, T-shaped uterus, and uncorrected intrauterine adhesions all significantly reduce implantation rate. 3. Hydrosalpinx: Fluid reflux can be toxic to embryos. After hysteroscopic ligation or resection, the live birth rate can be increased by 15-20 percentage points. When the sperm DNA fragmentation index (DFI) exceeds 30%, the rate of high-quality blastocysts decreases and the risk of miscarriage increases. 5. Basic diseases: uncontrolled diabetes, thyroid dysfunction, and positive autoantibodies may interfere with placental formation. Before cross-border patients go to the United States, it is recommended to complete the above assessment in China and undergo surgery or medication intervention if necessary to reduce their stay time and expenses in the United States.

7、 Common misconceptions in cross-border medical treatment

Misconception 1: Only focus on the live birth rate and ignore the cancellation rate. Some centers cancel their cycles prematurely for patients with poor ovarian response in order to maintain a high number, resulting in a decrease in the denominator. The 'live production rate per start-up cycle' should be checked simultaneously. Misconception 2: Treating PGT-A as a "master key". PGT-A can only screen for chromosome number, cannot detect monogenic diseases, and cannot improve embryo quality itself; If there are few blastocysts, there may be a dilemma of "no embryos to be detected". Misconception 3: Believing that there is no legal risk in the United States. Each state has different regulations on embryo disposal, ownership of remaining embryos, and scope of gamete use. When signing contracts, it is necessary to specify the freezing storage period, renewal standards, and disposal methods. Misconception 4: Neglecting laboratory quality control. CAP/CLAI in the United States conducts blind sampling of laboratories every year, but there are still small institutions that experience fluctuations due to personnel turnover. You can check the "hours of continuing education for embryologists" of the laboratory over the years on the SART official website. Misconception 5: mistaking "highest success rate" for "my success rate". Individualized prediction should use SART Patient Predictor (a free online tool), enter age AMH、BMI、 The system will provide five probability intervals based on more than ten parameters such as the number of past cycles and whether ICSI has been used, which is more realistic than simply looking at the rankings.

8、 How to establish a personal expectation model

Step 1: Obtain key indicators of oneself - age, AMH, AFC (basal antral follicle count) BMI、 Uterine evaluation and sperm DFI. Step 2: Input data into SART Predictor and record the benchmark value X for "single full-term live birth rate". Step 3: Adjust according to the gap between the selected hospital and CDC: If the average live birth rate of the same age group in the hospital is higher than the national average by 10%, the individual probability can be increased by 5-7%; If it is lower than the average, it will be lowered. Step 4: Consider embryo testing factors - if PGT-A is planned and the number of blastocysts is ≥ 5, the final probability can be further increased by 3-5%. Step 5: Calculate according to the "cumulative" thinking: a 35 year old female has a single cycle live birth rate of 55%, with a cumulative rate of 80% for two cycles and 90% for three cycles. Incorporate budget, physical endurance, and psychological thresholds together to determine how many cycles to prepare for.

9、 The marginal effect between cost and success rate

The average cost of a single cycle of autologous IVF in the United States is $12000- $14000, excluding medication costs. The cost of medication varies from $2500 to $6000 due to differences in ovarian reactions. PGT-A is charged based on the number of embryos, with 5-7 embryos costing approximately $5500. If the first transplant is unsuccessful, the second unfreezing transplant costs approximately $4000. Taking 35 years old with a single cycle live birth rate of 55% as an example, the expected cost of holding a baby is approximately $32700 (14000+4000)/0.55; If two egg retrieval attempts are required, the cost increases to approximately $50000. The "marginal gain" corresponding to the success rate is evident in the top centers: when the live birth rate increases from 55% to 65%, with the same budget of $50000, the cumulative success rate increases from 90% to 96%, which can reduce patient psychological and time losses. For women over 38 years old, the gap is more significant, so families in the older age group tend to choose institutions with more advanced laboratory technology when their budget allows.

10、 Outlook for 2024: Technological iteration and data transparency

1. AI Embryo Evaluation: A multi center randomized controlled trial in 2023 showed that deep learning models have an AUC of 0.93 for predicting blastocyst implantation, which is 8% higher than traditional morphological scores. It is expected to enter commercial use in 2024. 2. Non invasive PGT-A: Chromosome ploidy is detected by free DNA in embryo culture medium to avoid potential damage to embryos from biopsy. Three prospective trials have been registered and preliminary results may be announced by the end of 2024. 3. Large scale reassessment of endometrial receptivity gene profiling (ERA): ASRM is leading a 10000 person cohort to verify whether ERA truly improves live birth rates in first-time transplant patients, and the results will rewrite clinical guidelines. 4. Speed up the release of CDC data: The report that was originally planned to be delayed by 2 years is planned to be shortened to 1 year, and the data for the whole year of 2022 can be queried in the spring of 2025 to reduce the lag in patient information. 5. Remote monitoring: The US FDA has approved multiple home hormone microneedle patches. Cross border patients can upload real-time pharmacokinetic data, and US physicians can adjust the dosage online to reduce their stay in the US by 3-5 days.

conclusion

The success rate of IVF in the United States is not a simple number, but a probability curve drawn by age, ovarian reserve, uterine environment, laboratory level, embryo testing strategy, and personal budget. The public reports of CDC and SART provide the most reliable coordinate system for this curve to date, but coordinate systems cannot replace rational judgment. Learn to verify back and forth between official data and personalized prediction tools in order to translate "group probability" into "individual expectations" and avoid being misled by marketing rhetoric. The road to the United States is not easy, but when you can break down numbers with a professional perspective and manage expectations with scientific models, you have already turned the biggest uncertainty into an assessable, tolerable, and adjustable risk. May every reader be able to make the most suitable decision for themselves on the track illuminated by data light.

This article link:https://bken.loadskill.com/usivf/453.html